ADVASPRAY Trademark

Trademark Overview

On Wednesday, September 27, 2023, a trademark application was filed for ADVASPRAY with the United States Patent and Trademark Office. The USPTO has given the ADVASPRAY trademark a serial number of 79382317. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, January 15, 2025. This trademark is owned by APTAR FRANCE SAS. The ADVASPRAY trademark is filed in the Medical Instrument Products category with the following description:

Single dose nasal spray delivery devices sold empty and directly to manufacturers of drugs and pharmaceutical preparations for use in connection with medicines in liquid or powder form offered under different end-consumer facing marks.
advaspray

General Information

Serial Number79382317
Word MarkADVASPRAY
Filing DateWednesday, September 27, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, January 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkADVA SPRAY
Goods and ServicesSingle dose nasal spray delivery devices sold empty and directly to manufacturers of drugs and pharmaceutical preparations for use in connection with medicines in liquid or powder form offered under different end-consumer facing marks.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPTAR FRANCE SAS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 7, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, May 8, 2024ASSIGNED TO EXAMINER
Friday, May 10, 2024NON-FINAL ACTION WRITTEN
Saturday, May 11, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 23, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 23, 2024REFUSAL PROCESSED BY MPU
Tuesday, June 11, 2024REFUSAL PROCESSED BY IB
Monday, August 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 15, 2025FINAL REFUSAL WRITTEN
Wednesday, January 15, 2025FINAL REFUSAL E-MAILED
Monday, March 31, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 3, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 19, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, March 31, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Related Keywords

advaspray powder form liquid medicines connection offered under marks facing consumer